TEL AVIV, Israel, Nov. 30, 2017 /PRNewswire/ -- Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced that its Annual General
The agenda of the meeting is as follows:
(1) election of Izhak Tamir and Eric Paneth to the Board of Directors
(2) reappointment of Kost Forer Gabbay and Kasierer, a member of Ernst & Young Global, as independent auditors; and
(3) consideration of audited financial statements for the year ended December 31, 2016
Items 1 and 2 require the approval of a simple majority of the shares voted on the matter. Item 3 will not involve a vote of the shareholders.
The record date for the meeting is December 5, 2017. Tikcro will send its shareholders of record a proxy statement describing the various matters to be voted upon at the meeting, along with a proxy card enabling them to indicate their vote on each matter.
About Tikcro Technologies:Tikcro Technologies Ltd. (OTCQB: TIKRF) supports early stage development in growth areas, with a focus on biotechnology projects originated in Israeli academic centers. Tikcro is engaged with development of certain antibodies selected and verified in pre-clinical trials with a focus on antibodies targeting immune modulator pathways for cancer treatment. For more information, visit Tikcro's website at www.tikcro.com.
View original content:http://www.prnewswire.com/news-releases/tikcro-technologies-announces-2017-annual-general-meeting-300564586.html
SOURCE Tikcro Technologies Ltd.
Subscribe to our Free Newsletters!
A prosthetic heart valve is an artificial device surgically implanted into the heart to replace a ...
PUVA or photochemotherapy is used to treat several skin disorders with the help of UV light and the ...
Breathing in unclean air due to increasing air pollution could cause kidney damage with resultant ...View All